The deflnitive mammalian kidney forms as the result of reciprocal interactions between the ureteric bud epithelium and metanephric mesenchyme. As osteogenic protein 1 (OP-i/bone morphogenetic protein 7), a member of the TGF-.8 superfamily of proteins, is expressed predominantly in the kidney, we examined its involvement during metanephric induction and kidney differentiation. We found that OP-1 mRNA is expressed in the ureteric bud epithelium before mesenchymal condensation and is subsequently seen in the condensing mesenchyme and during glomerulogenesis. Mouse kidney metanephric rudiments cultured without ureteric bud epithelium failed to undergo mesenchymal condensation and further epithelialization, while exogenously added recombinant OP-1 was able to substitute for ureteric bud epithelium in restoring the induction of metanephric mesenchyme. This OP-i-induced nephrogenic mesenchyme differentiation follows a developmental pattern similar to that observed in the presence of the spinal cord, a metanephric inducer. Blocking OP-1 activity using either neutralizing antibodies or antisense oligonucleotides in mouse embryonic day 11.5 mesenchyme, cultured in the presence of metanephric inducers or in intact embryonic day 11.5 kidney rudiment, greatly reduced metanephric differentiation. These results demonstrate that OP-1 is required for metanephric mesenchyme differentiation and plays a functional role during kidney development.
TGF-.8 superfamily of proteins, is expressed predominantly in the kidney, we examined its involvement during metanephric induction and kidney differentiation. We found that OP-1 mRNA is expressed in the ureteric bud epithelium before mesenchymal condensation and is subsequently seen in the condensing mesenchyme and during glomerulogenesis. Mouse kidney metanephric rudiments cultured without ureteric bud epithelium failed to undergo mesenchymal condensation and further epithelialization, while exogenously added recombinant OP-1 was able to substitute for ureteric bud epithelium in restoring the induction of metanephric mesenchyme. This OP-i-induced nephrogenic mesenchyme differentiation follows a developmental pattern similar to that observed in the presence of the spinal cord, a metanephric inducer. Blocking OP-1 activity using either neutralizing antibodies or antisense oligonucleotides in mouse embryonic day 11.5 mesenchyme, cultured in the presence of metanephric inducers or in intact embryonic day 11.5 kidney rudiment, greatly reduced metanephric differentiation. These results demonstrate that OP-1 is required for metanephric mesenchyme differentiation and plays a functional role during kidney development.
The metanephros arises when the ureteric bud grows into the primitive nephrogenic mesoderm and induces the formation of metanephric tubules (1) (2) (3) (4) . The cells that are destined to convert into nephrons aggregate around the branching tips of the ureteric bud to undergo condensations characterized by the expression of specific markers, such as WT-1, Wnt-4, Pax-2, uvomorulin (E-cadherin), and laminin (5) (6) (7) (8) (9) . The process of metanephric induction can be prevented in vivo by interruption of nephric duct ingrowth and can be modeled in vitro, where the inducing tissue can be homologous (ureteric bud) or heterologous (spinal cord or salivary gland).
The signal that induces in vitro tubulogenesis has not yet been fully characterized. A variety of molecules (for review, see ref. 10 ) participate in metanephric differentiation in vitro, including transferrin, GD3 ganglioside, and laminin (9) . In addition, several growth factors and their receptors influence metanephric differentiation, including transforming growth factor (TGF)-a and -, (11, 12) , basic fibroblast growth factor (13) , insulin-like growth factor I and 11 (14) , insulin-like growth factor I receptor (15) , nerve growth factor receptor (16) , epidermal growth factor (12) and activin (17) , hepatocyte growth factor and its presumptive receptor, the met gene product (18) . Recently, Wnt-1 spatial expression has been shown to be capable of initiating condensation and tubulogenesis in uninduced mesenchyme (19) . Although several growth factors such as insulin-like growth factor I and insulinlike growth factor II (20, 21) and hepatocyte growth factor (22) were shown to stimulate metanephric development in vitro, the kidneys appeared to be normal in the null mutation mice. On the other hand, mice lacking WT-1 (23), Wnt-4 (6), or Pax-2 (24), all manifest renal aplasia, suggesting that these molecules are critical in metanephric development.
Bone morphogenetic proteins (BMPs)/osteogenic proteins (OPs) are growth and differentiation factors and are members of the TGF-3 superfamily. These proteins were identified based on their ability to induce the formation of endochondral bone at extraskeletal sites (for review, see ref. 25) . Several BMPs/OPs are also present at sites of epithelial-mesenchymal interaction during mammalian development (26) (27) (28) (29) . The kidney has been identified as the major site for synthesis of OP-1 during human and mouse development (30) and BMP-7/ OP-1 null mutation mice manifest several renal dysplasia (31) (32) .
In the present study, we investigated the temporal and spatial distribution of OP-1 RNA during early embryonic kidney development and the role of OP-1 in metanephric differentiation in vitro. These developmental and functional studies provide evidence that OP-1 mediates mesenchymalepithelial signaling that are required for normal metanephric development. (26, 28 The AS-1 and S-1 sequences correspond to nucleotides in the pro region of OP-1; AS-2 and S-2 sequences correspond to nucleotides in the RXXR region of the pro OP-1 maturation site. AS-3 and S-3 OP-1 covers nucleotides just before the first cysteine of the mature region. Phosphorothioate oligonucleotides were prepared on a DNA synthesizer (Millipore) and purified using HPLC. Control oligonucleotides include sense and nonsense oligonucleotides, which were selected to contain a similar base composition that lacks sequences complementary to other mammalian mRNAs.
MATERIALS AND METHODS
Recombinant OP-1, cDNA, and Antibodies. Recombinant OP-1 was used in either a mature or soluble form (33) related member of the TGF-f3 superfamily, and TGF-,B1 had no effect on metanephric differentiation under identical conditions (data not shown).
Blocking studies show that when Ei1.5 nephrogenic mesenchyme was grown in the presence of an inducer (spinal cord), addition of OP-1 antisense oligonucleotides inhibited the induction of the mesenchymal condensation and subsequent tubulogenesis, as followed by the expression of specific marker genes ( Fig. 2 and Table 1 ). Addition of 2.5 ,uM antisense, sense, or nonsense OP-1 oligonucleotide had no effect on WT-1 mRNA expression in metanephric mesenchyme with or without an inducer or with exogenous recombinant OP-1 (data not shown). On the other hand, Pax-2 mRNA was absent from uninduced mesenchyme but appeared when metanephric rudiments were cultured with spinal cord or added OP-1. OP-1 antisense oligonucleotide inhibited Pax-2 expression, while OP-1 sense oligonucleotide had no effect. Patterns of expression similar to Pax-2 mRNA were also observed for Wnt-4 mRNA (data not shown) and laminin a-i mRNA using the same culture conditions (Fig. 2) .
OP-1 Autoregulates Its Expression During Metanephric Differentiation. Analysis of the Ell.5 metanephric explants cultured in the presence of ureteric bud for 3 days showed a high level of OP-1 gene expression in the mesenchymal cells adjacent to the epithelium (Fig. 3 C and D) . However, when explants were cultured without ureteric bud, there was no OP-1 mRNA expression observed (Fig. 3A and B) . These data indicate that OP-1 expression in mesenchyme is dependent on epithelial-mesenchymal interactions during budding of the ureter into the condensing mesenchyme. The addition of 5-10 ng of OP-1 per ml to the nephrogenic mesenchyme cultured in the absence of ureteric bud epithelium turned on OP-1 mRNA expression within 48-72 h in the condensing cells (Fig. 3F) , while TGF-f31 and/or BMP-had no effect on OP-1 mRNA expression (data not shown). Blocking studies using OP-1 (Fig. 4 A, B , E, and F; Table 2 ). The OP-1 (20 ng per ml) reduced proliferation as assessed by DNA content and increased the number of mesenchymal condensates (data not shown). These results suggest that OP-1 may influence mesenchymal cell condensation and subsequent tubulogenesis, perhaps by governing local OP-1 expression during kidney morphogenesis.
Intact kidney rudiments treated with sense or nonsense OP-1 oligonucleotides exhibited a normal growth and differentiation pattern comparable to control cultures, whereas antisense oligonucleotide at a concentrations of 2.5 ,uM inhibited mesenchymal cell condensations and the formation of glomeruli (Fig. 4 C, D , G, and H; Table 2 ). Histological evaluation showed that the mesenchyme was loosely organized with few or no comma-or S-shaped bodies present, and limited ureteric bud branching was observed. Similar effects were found using specific OP-1 neutralizing monoclonal antibodies 1B12 or 12G3 (Fig. 4 I and J) . The blocking of OP-1 activity by OP-1 antibodies or AS-3 oligonucleotide does not appear due to premature cell death or altered cell fate commitment, as determined by the viability score (data not shown). Control experiments showed that AS-3 oligonucleotide inhibited OP-1 mRNA in cultured kidney rudiments but had no effect on BMP-3 expression (Fig. 5) . In the presence of sense and nonsense oligonucleotides, the OP-1 mRNA expression levels were maintained (Fig. 5) (E) . Culture in the presence of 20 ng of OP-1 per ml increased the number of structures expressing Pax-2 (B) and uvomorulin (F). Culture in the presence of 2.5 ,uM OP-1 sense oligonucleotide S-3 had no effect on the expression of Pax-2 protein (C, with Inset) or uvomorulin (H). By contrast, culture in the presence of 2.5 ,uM OP-1 antisense oligonucleotide AS-3 reduced the number of structures expressing Pax-2 (D, with Inset) and uvomorulin (G). Similarly, culture in the presence of 5 ,ug of OP-1 specific monoclonal antibody per ml inhibited uvomorulin expression (I) while 5 ,ug of the irrelevant herpes simplex specific monoclonal antibody per ml had no effect. (Tissue sections were photographed in brightfield at a magnification of x 100, except for the metanephric rudiments photographed in phase contrast at x25 in the Insets of C and D. D, bar = 200 ,um.) subsequent tubulogenesis; and (iii) the blocking of OP-1 activity using either neutralizing antibodies or antisense oligonucleotides in the kidney rudiment explant cultures inhibits the developmental cascade of cellular events, leading to metanephric differentiation. These observations collectively indicate that OP-1 is required for kidney development and comprise the required embryological criteria for an inducing morphogenic signal (34) . The finding that OP-1 is expressed in other known metanephric inducers including spinal cord and salivary gland (28) further supports the role of OP-1 for metanephric differentiation. 5 ,ug/ml 14 0 1 13 0 1 13 Mouse El 1.5 metanephric mesenchyme with ureteric bud left intact was cultured for 72 h in chemically defined medium as described, with the following factors: medium alone, OP-1, OP-1 antisense oligonucleotide AS-3, OP-1 sense oligonucleotide S-3, nonsense oligonucleotide NS-3, OP-1-specific monoclonal antibody (lB12) and herpes simplex specific antibody (HS). The number of branching tubules and glomeruli was counted, using both phase contrast and hematoxylinand eosin-stained serial sections. Poly(A)+ RNA was prepared, and Northern analysis was performed using an OP-1-specific cDNA probe (lanes 1 and 3) , a BMP-3-specific cDNA probe (lane 4), and a normalizing gene, a glyceraldehyde-6-phosphate dehydrogenase (GAPDH)-specific cDNA probe. The x-ray films were exposed for 6 days to membranes hybridized with OP-1 and BMP-3 probes and for 18 h to the same membrane hybridized with a GAPDH probe. RNA size markers are indicated at right (9, 7, 4.2, 2.2, and 1.3 kb). The OP-1 mRNA expression was similar with sense and nonsense oligonucleotides but was substantially reduced following culture with antisense oligonucleotide. Antisense oligonucleotide had no effect on BMP-3 RNA expression.
The use of antisense oligonucleotides in metanephric cultures requires precise documentation of culture conditions, uptake, and suppression of RNA expression (35) (36) (37) (38) . In the present study, we show that OP-1 AS-3 oligonucleotide specifically inhibits OP-1 expression in both basal medium (MEM) and enriched medium (IMEM) at concentrations up to 2.5 ,tM.
In addition, we found that the oligonucleotides are taken up by mesenchymal cells, while uptake was substantially less by the El 1.5 ureteric bud epithelium and was absent from the ureteric bud epithelium at later time points. The ureteric bud epithelium has been previously noted to be refractory to oligonucleotide entry (35) (36) (37) . Further, we showed that antisense oligonucleotide selectively reduced OP-1 mRNA expression, while sense and nonsense oligonucleotides had no effect. Finally, neutralizing antibodies intended to block the activity of OP-1 present in metanephric cultures prevented differentiation. Thus, reduction of OP-1 mRNA expression and inhibition of OP-1 protein activity both suppressed tubulogenesis in metanephric rudiments.
Two recent reports show that the majority of BMP-7/OP-1 null mutation mice die of renal failure within the first day of postnatal life (31, 32) . Luo et al. (31) reported the presence of few mesenchymal condensations surrounding ureteric buds at E12.5 and found no glomeruli or tubules at E14.5. The expression of WT-1, Pax-2, and Wnt-4 RNA was greatly reduced or nearly absent from the mesenchyme, particularly at E14.5. We suggest that BMP-7/OP-1 is a critical early inducer of nephrogenesis and that placental transfer of maternal BMP-7/OP-1 might partially rescue the embryo and explain the presence of few induced mesenchymal structure. The phenotype reported by Dudley et al. (32) was somewhat different, with normal metanephric development up to E14.5 and appropriate expression of Pax-2, Pax-8, and Wnt-4. After this time, mutant kidney exhibited a severely disorganized architecture, few mesenchymal aggregates, and reduced expression of Pax-2, Pax-8, and Wnt-4 within the induced mesenchymal structures, while ureteric bud differentiation was preserved. The authors suggest that the absence of BMP-7/ OP-1 has little effect on the inductive interaction between ureteric bud and mesenchyme but instead prevents the continued survival and/or differentiation of mesenchymal and epithelial components. Although the reasons for the differences in timing and severity of metanephric defects between these two null mutation mouse models are not readily apparent, these studies clearly demonstrate that BMP-7/OP-1 is required for normal metanephric development.
The organ culture approach used in the present study shows that OP-1 may act as an inducer of undifferentiated mesenchyme, as evidenced by the presence of OP-1 RNA transcripts in various inducing tissues, including uretric bud, and by the ability of recombinant OP-1 to stimulate metanephric development in vitro. OP-1 may also prevent apoptosis of uninduced mesenchyme or promote survival of mesenchymal cells that have been induced, as we have used E11.5 metanephric rudiments that have been exposed in vivo for several hours to the advancing ureteric bud and may have already received inductive signal(s). Furthermore, OP-1 may function as a differentiation factor, promoting the epithelial conversion of the mesenchyme and/or the continued branching of the ureteric bud, but it may still be dependent upon an inducing factor to initiate the process. Thus, the action of OP-1 in metanephric rudiment system does not allow to unequivocally assign the role of OP-1 as an inductive or survival or differentiation factor. It is likely that OP-1 may govern overall cellular events associated with kidney morphogenesis.
In conclusion, we have shown that OP-1 transcripts are localized in vivo to the ureteric bud and subsequently to the induced mesenchyme and that OP-1 is required for and can promote metanephric differentiation in vitro. Thus OP-1 plays a critical role in the epithelial-mesenchymal conversion of the metanephros and may serve as a signal for metanephric induction, a survival factor, or enhancer of nephrogenic mesenchyme differentiation. These data suggest a model in which the temporal and spatial expression of OP-1 gene acts in concert with the appropriate responding cell type and permissive microenvironment to confer biological specificity during tissue morphogenesis (39, 40) .
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